Lilly Sues Hetero To Block Generic Strattera
Eli Lilly & Co. filed suit in New Jersey on Monday in an effort to keep India's Hetero Drugs Ltd. from launching a generic version of attention deficit hyperactivity disorder treatment...To view the full article, register now.
Already a subscriber? Click here to view full article